News & Updates
Filter by Specialty:
Azithromycin use poses acute heart failure, mortality risks for some COVID-19 patients
Exposure to azithromycin may put patients with COVID‐19 and history of cardiovascular disease (CVD) at higher risks of acute heart failure and death, as reported in a study.
Azithromycin use poses acute heart failure, mortality risks for some COVID-19 patients
18 Jul 2023
Metformin discontinuation ups cardio-renal events in CKD patients with diabetes
Putting an end to the use of metformin may lead to a higher risk of cardio-renal events in patients with diabetes and advanced chronic kidney disease (CKD), regardless of their cardiovascular disease (CVD) status, suggests a study presented at ADA 2023.
Metformin discontinuation ups cardio-renal events in CKD patients with diabetes
18 Jul 2023
Theophylline shows promise in SCI-induced bradycardia
Use of theophylline as an adjunctive therapy appears to lead to favourable outcomes among patients with bradycardia due to acute spinal cord injury (SCI) with an acceptable response to this agent, suggest the results of a study.
Theophylline shows promise in SCI-induced bradycardia
18 Jul 2023
Phase III data support long-term efficacy of TAF against HBV
Two phase III studies presented at EASL 2023 reflected the long-term efficacy of tenofovir alafenamide (TAF) for individuals with HBeAg*-positive and HBeAg-negative chronic hepatitis B virus (HBV).
Phase III data support long-term efficacy of TAF against HBV
18 Jul 2023
Advanced liver fibrosis a red flag for poor outcomes in T2D
Among individuals with type 2 diabetes (T2D), the risk of poor outcomes such as heart failure and hospitalizations is high in the presence of advanced liver fibrosis, according to a study.